Researchers from Tufts Medical Center analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs.
At the beginning of August, Express Scripts and CVS Health announced formulary exclusions aimed at battling rising prescription drug prices. Notably, diabetes drugs took a hit with Express Scripts choosing not to cover Victoza and CVS Health announcing is would pull Lantus, along with its successor Toujeo, in favor of the biosimilar Basaglar.
Researchers from Tufts Medical Center analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs. They found that in most cases, exclusion policies work.
However, while most studies suggested that drug exclusions save money, in some cases savings from less expensive alternatives were offset by other healthcare spending, such as increased office visits or hospitalizations.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More